1496 related articles for article (PubMed ID: 29277561)
1. Nuclear Receptor Subfamily 1 Group D Member 1 Regulates Circadian Activity of NLRP3 Inflammasome to Reduce the Severity of Fulminant Hepatitis in Mice.
Pourcet B; Zecchin M; Ferri L; Beauchamp J; Sitaula S; Billon C; Delhaye S; Vanhoutte J; Mayeuf-Louchart A; Thorel Q; Haas JT; Eeckhoute J; Dombrowicz D; Duhem C; Boulinguiez A; Lancel S; Sebti Y; Burris TP; Staels B; Duez HM
Gastroenterology; 2018 Apr; 154(5):1449-1464.e20. PubMed ID: 29277561
[TBL] [Abstract][Full Text] [Related]
2. Lactate reduces liver and pancreatic injury in Toll-like receptor- and inflammasome-mediated inflammation via GPR81-mediated suppression of innate immunity.
Hoque R; Farooq A; Ghani A; Gorelick F; Mehal WZ
Gastroenterology; 2014 Jun; 146(7):1763-74. PubMed ID: 24657625
[TBL] [Abstract][Full Text] [Related]
3. REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
Hong H; Cheung YM; Cao X; Wu Y; Li C; Tian XY
Biochem Pharmacol; 2021 Oct; 192():114701. PubMed ID: 34324866
[TBL] [Abstract][Full Text] [Related]
4. RORγ regulates the NLRP3 inflammasome.
Billon C; Murray MH; Avdagic A; Burris TP
J Biol Chem; 2019 Jan; 294(1):10-19. PubMed ID: 30455347
[TBL] [Abstract][Full Text] [Related]
5. Rev-erbα regulates hepatic ischemia-reperfusion injury in mice.
Lin Y; Lin L; Gao L; Wang S; Wu B
Biochem Biophys Res Commun; 2020 Sep; 529(4):916-921. PubMed ID: 32819599
[TBL] [Abstract][Full Text] [Related]
6. The LPS/D-Galactosamine-Induced Fulminant Hepatitis Model to Assess the Role of Ligand-Activated Nuclear Receptors on the NLRP3 Inflammasome Pathway In Vivo.
Sebti Y; Ferri L; Zecchin M; Beauchamp J; Mogilenko D; Staels B; Duez H; Pourcet B
Methods Mol Biol; 2019; 1951():189-207. PubMed ID: 30825154
[TBL] [Abstract][Full Text] [Related]
7. Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3.
Xia Y; Wang P; Yan N; Gonzalez FJ; Yan T
Cell Death Dis; 2021 Feb; 12(2):174. PubMed ID: 33574236
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin alleviates LPS/ D-GalN-induced acute liver failure by activating the PGC-1α/ Nrf2 pathway to reduce oxidative stress and inflammatory response.
Wang L; Wang X; Kong L; Wang S; Huang K; Wu J; Wang C; Sun H; Liu K; Meng Q
Int Immunopharmacol; 2021 Nov; 100():108159. PubMed ID: 34555641
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
Kim SJ; Lee SM
Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
[TBL] [Abstract][Full Text] [Related]
10. Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis.
Gong Z; Zhou J; Zhao S; Tian C; Wang P; Xu C; Chen Y; Cai W; Wu J
Oncotarget; 2016 Dec; 7(51):83951-83963. PubMed ID: 27924062
[TBL] [Abstract][Full Text] [Related]
11. Frontline Science: Specialized proresolving lipid mediators inhibit the priming and activation of the macrophage NLRP3 inflammasome.
Lopategi A; Flores-Costa R; Rius B; López-Vicario C; Alcaraz-Quiles J; Titos E; Clària J
J Leukoc Biol; 2019 Jan; 105(1):25-36. PubMed ID: 29601102
[TBL] [Abstract][Full Text] [Related]
12. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
13. NLRP3 Inflammasome Regulates Development of Systemic Inflammatory Response and Compensatory Anti-Inflammatory Response Syndromes in Mice With Acute Pancreatitis.
Sendler M; van den Brandt C; Glaubitz J; Wilden A; Golchert J; Weiss FU; Homuth G; De Freitas Chama LL; Mishra N; Mahajan UM; Bossaller L; Völker U; Bröker BM; Mayerle J; Lerch MM
Gastroenterology; 2020 Jan; 158(1):253-269.e14. PubMed ID: 31593700
[TBL] [Abstract][Full Text] [Related]
14. Bavachin attenuates LPS-induced inflammatory response and inhibits the activation of NLRP3 inflammasome in macrophages.
Hung YL; Wang SC; Suzuki K; Fang SH; Chen CS; Cheng WC; Su CC; Yeh HC; Tu HP; Liu PL; Huang MY; Li CY
Phytomedicine; 2019 Jun; 59():152785. PubMed ID: 31009850
[TBL] [Abstract][Full Text] [Related]
15. NLRP3 is dispensable for d-galactosamine/lipopolysaccharide-induced acute liver failure.
Zhang W; Tao SS; Wang T; Li YT; Chen H; Zhan YQ; Yu M; Ge CH; Li CY; Ren GM; Yin RH; Yang XM
Biochem Biophys Res Commun; 2020 Dec; 533(4):1184-1190. PubMed ID: 33041005
[TBL] [Abstract][Full Text] [Related]
16. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
17. HBV inhibits LPS-induced NLRP3 inflammasome activation and IL-1β production via suppressing the NF-κB pathway and ROS production.
Yu X; Lan P; Hou X; Han Q; Lu N; Li T; Jiao C; Zhang J; Zhang C; Tian Z
J Hepatol; 2017 Apr; 66(4):693-702. PubMed ID: 28027970
[TBL] [Abstract][Full Text] [Related]
18. AMSC-derived exosomes alleviate lipopolysaccharide/d-galactosamine-induced acute liver failure by miR-17-mediated reduction of TXNIP/NLRP3 inflammasome activation in macrophages.
Liu Y; Lou G; Li A; Zhang T; Qi J; Ye D; Zheng M; Chen Z
EBioMedicine; 2018 Oct; 36():140-150. PubMed ID: 30197023
[TBL] [Abstract][Full Text] [Related]
19. REV-ERBα integrates colon clock with experimental colitis through regulation of NF-κB/NLRP3 axis.
Wang S; Lin Y; Yuan X; Li F; Guo L; Wu B
Nat Commun; 2018 Oct; 9(1):4246. PubMed ID: 30315268
[TBL] [Abstract][Full Text] [Related]
20. Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages.
Yeon SH; Yang G; Lee HE; Lee JY
J Leukoc Biol; 2017 Jan; 101(1):205-215. PubMed ID: 27256568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
